Inventor · disambiguated record
Philip Huxley
Also filed as: HUXLEY PHILIP
18 granted patents·5 pending applications·184 citations·filing 1986–2023
93Inventor score
Files withBICYCLETX LTD5BRITISH BIOTECH PHARM4ACTIVE BIOTECH AB3ANDREWS MARTIN JAMES INGLIS2DUCENTIS BIOTHERAPEUTICS LTD2
Top patents by PatentIndex Score
23 records- 0197US11833211B2Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2BICYCLETX LTD·Filed 2022·Granted Dec 5, 2023·15 cites·20 claims
- 0296US11484602B2Bicyclic peptide ligands specific for EphA2BICYCLETX LTD·Filed 2018·Granted Nov 1, 2022·16 cites·21 claims
- 0395US11696956B2Bicyclic peptide ligands specific for EphA2BICYCLETX LTD·Filed 2018·Granted Jul 11, 2023·18 cites·19 claims
- 0486US5742796AGraphics system with color space double buffering3DLABS INC LTD·Filed 1995·Granted Apr 21, 1998·86 cites·23 claims
- 0585US2024189436A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2BICYCLETX LTD·Filed 2023·Application pending·0 cites
- 0683US2024000957A1BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2BICYCLETX LTD·Filed 2023·Application pending·0 cites
- 0779US6569847B1Substituted azetidin-2-ones as cysteine protease inhibitorsNAEJA PHARMACEUTICALS INC·Filed 2000·Granted May 27, 2003·22 cites·12 claims
- 0877US7893058B2Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Feb 22, 2011·2 cites·55 claims
- 0977US5917090AMatrix metalloproteinase inhibitorsBRITISH BIOTECH PHARM·Filed 1996·Granted Jun 29, 1999·17 cites·11 claims
- 1070US7291612B2Immunomodulatory compoundsACTIVE BIOTECH AB·Filed 2006·Granted Nov 6, 2007·2 cites·19 claims
- 1166US6790834B1Cytostatic agentsBRITISH BIOTECH PHARM·Filed 2000·Granted Sep 14, 2004·1 cites·46 claims
- 1262US7081456B2Immunomodulatory compoundsACTIVE BIOTECH AB·Filed 2003·Granted Jul 25, 2006·2 cites·20 claims
- 1356US2025026805A1Novel proteinsDUCENTIS BIOTHERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 1454US8173656B2Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2010·Granted May 8, 2012·0 cites·12 claims
- 1552US8178530B2Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseasesANDREWS MARTIN JAMES INGLIS·Filed 2010·Granted May 15, 2012·0 cites·53 claims
- 1649US8236827B2CompoundsPOTTER GERARD ANDREW·Filed 2009·Granted Aug 7, 2012·0 cites·8 claims
- 1746US2015057443A1Cycloalkyl Amine CompoundsPREXA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1844US11203628B2CD200 mutants and its usesDUCENTIS BIOTHERAPEUTICS LTD·Filed 2017·Granted Dec 21, 2021·0 cites·19 claims
- 1940US7674906B2Tetracyclic immunomodulatory compoundsACTIVE BIOTECH AB·Filed 2003·Granted Mar 9, 2010·0 cites·16 claims
- 2040US6462023B1Cytostatic agentsBRITISH BIOTECH PHARM·Filed 1998·Granted Oct 8, 2002·2 cites·32 claims
- 2140US2013023567A1Novel CompoundsSPEAR THERAPEUTICS LTD·Filed 2012·Application pending·0 cites
- 2232US6169075B1Cytostatic agentsBRITISH BIOTECH PHARM·Filed 1997·Granted Jan 2, 2001·1 cites·26 claims
- 2331US4727075AFungicidal 5-substituted pyrimidine derivatives, compositions, and method of use thereforCIBA GEIGY CORP·Filed 1986·Granted Feb 23, 1988·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Philip Huxley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →